Agenus, Inc. (AGEN) - Financial and Strategic SWOT Analysis Review

Date: April 26, 2016
Pages: 47
Price:
US$ 125.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: A913AB09098EN
Leaflet:

Download PDF Leaflet

Agenus, Inc. (AGEN) - Financial and Strategic SWOT Analysis Review
Agenus, Inc. (AGEN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Agenus, Inc. (Agenus) is a pharmaceutical company. It focuses on the development and commercialization of immunotherapeutics for the treatment of diseases in the fields of cancer and infectious diseases. Its business activities include product research and development, regulatory and clinical affairs, manufacturing, corporate finance and development, business development, marketing, intellectual property prosecution and administrative functions. The company's key technology portfolio includes Checkpoint Antibody Program, Saponin Platform and Heat Shock Protein (HSP) Platform. Its major products in the pipeline include candidates for the treatment of genital herpes, glioma, and multiple cancer types and infectious diseases such as malaria and shingles. The company has partnerships with several pharmaceutical companies such as GSK, Incyte, and universities such as UC San Francisco and UW Seattle. It operates in the US and Europe. Agenus is headquartered in Lexington, Massachusetts, the US.

Agenus, Inc. Key Recent Developments

Mar 03, 2016: Agenus Reports Fourth Quarter and Full Year 2015 Financial and Operational Results and Recent Highlights
Oct 27, 2015: Agenus Reports Third Quarter 2015 Financial Results
Jul 23, 2015: Agenus Reports Second Quarter 2015 Financial Results
Jun 17, 2015: Agenus Appoints C. Evan Ballantyne as Chief Financial Officer
Jun 01, 2015: Updated Phase 2 Data of Prophage In Newly Diagnosed GBM Presented at ASCO Show Improvement in Median Progression Free Survival and Overall Survival Independently of Prognostic Markers

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers. - The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

    Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

    Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

    Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

    Note: Some sections may be missing if data is unavailable for the company
  • SECTION 1 - ABOUT THE COMPANY

    Agenus, Inc. - Key Facts
    Agenus, Inc. - Key Employees
    Agenus, Inc. - Key Employee Biographies
    Agenus, Inc. - Major Products and Services
    Agenus, Inc. - History
    Agenus, Inc. - Company Statement
    Agenus, Inc. - Locations And Subsidiaries
    Head Office
    Other Locations & Subsidiaries

    SECTION 2 – COMPANY ANALYSIS

    Agenus, Inc. - Business Description
    Agenus, Inc. - Corporate Strategy
    Agenus, Inc. - SWOT Analysis
    SWOT Analysis - Overview
    Agenus, Inc. - Strengths
    Strength - Partnerships and Collaborations
    Strength - Strong In-house Research Capabilities
    Strength - Technology Platforms
    Agenus, Inc. - Weaknesses
    Weakness - Lack of Marketed Products
    Weakness - Competitive Positioning
    Agenus, Inc. - Opportunities
    Opportunity - Market Potential for QS-21 Adjuvant
    Opportunity - Business Initiatives
    Opportunity - Product Pipeline
    Agenus, Inc. - Threats
    Threat - Competitive Environment
    Threat - Dependence on Collaborators and Licensees
    Threat - Patent Expiry
    Agenus, Inc. - Key Competitors

    SECTION 3 – COMPANY FINANCIAL RATIOS

    Financial Ratios - Capital Market Ratios
    Financial Ratios - Annual Ratios
    Performance Chart
    Financial Performance
    Financial Ratios - Interim Ratios
    Financial Ratios - Ratio Charts

    SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

    Agenus, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
    Agenus, Inc., Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
    Agenus, Inc., Recent Deals Summary

    SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

    Mar 03, 2016: Agenus Reports Fourth Quarter and Full Year 2015 Financial and Operational Results and Recent Highlights
    Oct 27, 2015: Agenus Reports Third Quarter 2015 Financial Results
    Jul 23, 2015: Agenus Reports Second Quarter 2015 Financial Results
    Jun 17, 2015: Agenus Appoints C. Evan Ballantyne as Chief Financial Officer
    Jun 01, 2015: Updated Phase 2 Data of Prophage In Newly Diagnosed GBM Presented at ASCO Show Improvement in Median Progression Free Survival and Overall Survival Independently of Prognostic Markers
    Apr 23, 2015: Agenus Reports First Quarter 2015 Financial Results
    Feb 26, 2015: Agenus Reports Fourth Quarter and Full Year 2014 Financial Results

    SECTION 6 – APPENDIX

    Methodology
    Ratio Definitions
    About GlobalData
    Contact Us
    Disclaimer

    LIST OF TABLES

    Agenus, Inc., Key Facts
    Agenus, Inc., Key Employees
    Agenus, Inc., Key Employee Biographies
    Agenus, Inc., Major Products and Services
    Agenus, Inc., History
    Agenus, Inc., Subsidiaries
    Agenus, Inc., Key Competitors
    Agenus, Inc., Ratios based on current share price
    Agenus, Inc., Annual Ratios
    Agenus, Inc., Interim Ratios
    Agenus, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
    Agenus, Inc., Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
    Agenus, Inc., Recent Deals Summary
    Currency Codes
    Capital Market Ratios
    Equity Ratios
    Profitability Ratios
    Cost Ratios
    Liquidity Ratios
    Leverage Ratios
    Efficiency Ratios

    LIST OF FIGURES

    Agenus, Inc., Performance Chart (2011 - 2015)
    Agenus, Inc., Ratio Charts
    Agenus, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
    Agenus, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016
    Skip to top


    Ask Your Question

    Agenus, Inc. (AGEN) - Financial and Strategic SWOT Analysis Review
    Company name*:
    Contact person*:
    Phone/fax*:
    Email*:
    Request invoice
    Your enquiry:
    Please click on a Check Box below to confirm you are not a robot: